Avalyn Pharma Inc. Common Stock (AVLN) is a publicly traded the market company. As of June 3, 2026, AVLN trades at $25.58 with a market cap of $1.18B and a P/E ratio of 0.00. AVLN moved +0.00% today. Year to date, AVLN is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $25.05 to $32.23. Analyst consensus is strong buy with an average price target of $52.00. Rallies surfaces AVLN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for AVLN shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $25.58 |
| Market Cap | $1.18B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $32.23 |
| 52-Week Low | $25.05 |
| Volume | 9.62K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
3 analysts cover AVLN: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $52.00.